Suppr超能文献

新冠病毒疫苗接种后免疫性血小板减少性紫癜伴急性肝损伤

Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine.

机构信息

Hematology/Oncology, Long Island Jewish Medical Center Northwell Health Cancer Institute, New Hyde Park, New York, USA

Hematology/Oncology, Long Island Jewish Medical Center Northwell Health Cancer Institute, Lake Success, New York, USA.

出版信息

BMJ Case Rep. 2021 Jul 30;14(7):e242678. doi: 10.1136/bcr-2021-242678.

Abstract

A 26-year-old woman was sent to the emergency room by her primary care physician for a new petechial rash and thrombocytopenia 2 weeks after receiving the Moderna mRNA-1273 SARS-CoV-2 vaccine. Her hospital course was complicated by transaminitis. Her platelet count improved to normal on hospital day 5 after receiving intravenous steroids and intravenous immunoglobulin to treat her suspected diagnosis of immune thrombocytopenic purpura. Extensive workup for her thrombocytopenia and transaminitis was unremarkable including ruling out infectious, autoimmune and toxic causes. A liver biopsy was unrevealing and her transaminitis was improved on discharge. Although not proven, the temporal relationship of her vaccination with thrombocytopenia and abnormal liver enzymes points towards the Moderna mRNA-1273 SARS-CoV-2 vaccine as the most likely inciting factor.

摘要

一位 26 岁女性因新出现瘀点性皮疹和血小板减少,在接受 Moderna mRNA-1273 SARS-CoV-2 疫苗接种后 2 周,由初级保健医生转至急诊室。她的住院过程因肝氨基转移酶升高而变得复杂。在接受静脉注射类固醇和静脉注射免疫球蛋白治疗疑似免疫性血小板减少性紫癜后,她的血小板计数在住院第 5 天恢复正常。对她的血小板减少症和肝氨基转移酶升高进行了广泛的检查,包括排除感染、自身免疫和中毒原因,但均无明显异常。肝活检无异常发现,出院时肝氨基转移酶升高情况有所改善。虽然尚未证实,但她接种疫苗与血小板减少症和异常肝酶之间的时间关系表明,最有可能的诱发因素是 Moderna mRNA-1273 SARS-CoV-2 疫苗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验